BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19278615)

  • 1. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
    Eiken PA; Abrahamsen B
    Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation between studies and general practice].
    MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
    MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treating with what? Therapy for how long?].
    MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
    [No Abstract]   [Full Text] [Related]  

  • 6. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
    Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteoporosis screening: time to take responsibility.
    Mazanec D
    Arch Intern Med; 2004 May; 164(10):1047-8. PubMed ID: 15159261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alendronate (Fosamax 10 mg). The first amino-biphosphate for the treatment of women with postmenopausal osteoporosis].
    Geburtshilfe Frauenheilkd; 1996 Oct; 56(10 Suppl):1-4. PubMed ID: 9022376
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function and bisphosphonate safety.
    Ott SM; Drueke T; Elder G; Fukagawa M; Jorgetti V; Langman CB; Moe S; McCann L; Wang AY; Weisinger J; Wheeler D
    J Bone Miner Res; 2008 Mar; 23(3):453-4; author reply 455. PubMed ID: 17967135
    [No Abstract]   [Full Text] [Related]  

  • 13. Do not use bisphosphonate therapy indefinitely for fracture prevention.
    Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alendronate].
    Okazaki R
    Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 16. [Should bisphosphonate treatment be used for super-old patients with osteoporosis?].
    Harada A; Yamamoto S; Kurato S; Iwase T; Inoue K; Sasaki Y; Tanaka T; Fujita M; Nakano T; Ando F
    Nihon Ronen Igakkai Zasshi; 2006 Jul; 43(4):459-61. PubMed ID: 16937933
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of DNA damage in postmenopausal women under osteoporosis therapy.
    Bayram M; Soyer C; Kadioglu E; Sardas S
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):227-30. PubMed ID: 16504368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alendronate and vitamin D (Fosavance): persistence, adherence and importance of vitamin D].
    Grazio S; Morović-Vergles J
    Reumatizam; 2007; 54(2):89-92. PubMed ID: 18351154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
    Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
    Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
    [No Abstract]   [Full Text] [Related]  

  • 20. [New proposal concerning alendronate reimbursement].
    Halse J
    Tidsskr Nor Laegeforen; 2010 May; 130(10):1021. PubMed ID: 20489801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.